why is semaglutide being discontinued FDA ends shortage, closing the door on compounded Wegovy, Ozempic Older Americans quitting weight-loss drugs

For people already managing type 2 diabetes, the existing oral semaglutide Rybelsus (at lower doses of 714 mg, prescribed specifically for T2D) has a well-established track record on HbA1c reduction

Storage stability depends on peptide type and handling quality

In Phase 3 TRIUMPH-4, the rate was higher at 18.2% for the 12mg dose, but Eli Lilly noted this was heavily influenced by baseline BMI

During Treatment: GLP-1 is administered as a once-weekly injection

The presence of GLP-1 receptors in these reward pathways has prompted researchers to investigate whether GLP-1 agonists might influence behaviours beyond eating, including alcohol consumption

Using GLP-1 medicines should, therefore, complement your current strategies for managing diabetes and weight loss